hologic , inc .
notes to consolidated financial statements ( continued ) ( in thousands , except per share data ) the aggregate purchase price for suros of approximately $ 248000 ( subject to adjustment ) consisted of 2300 shares of hologic common stock valued at $ 106500 , cash paid of $ 139000 , and approximately $ 2600 for acquisition related fees and expenses .
the company determined the fair value of the shares issued in connection with the acquisition in accordance with eitf issue no .
99-12 , determination of the measurement date for the market price of acquirer securities issued in a purchase business combination .
the components and allocation of the purchase price , consists of the following approximate amounts: .

Net tangible assets acquired as of July 27, 2006
$12,000
In-process research and development
4,900
Developed technology and know how
46,000
Customer relationship
17,900
Trade name
5,800
Deferred income taxes
(21,300)
Goodwill
182,800
Estimated Purchase Price
$248,100

the acquisition also provides for a two-year earn out .
the earn-out will be payable in two annual cash installments equal to the incremental revenue growth in suros 2019 business in the two years following the closing .
the company has considered the provision of eitf issue no .
95-8 , accounting for contingent consideration paid to the shareholders of and acquired enterprise in a purchase business combination , and concluded that this contingent consideration represents additional purchase price .
as a result , goodwill will be increased by the amount of the additional consideration , if any , when it becomes due and payable .
as part of the purchase price allocation , all intangible assets that were a part of the acquisition were identified and valued .
it was determined that only customer lists , trademarks and developed technology had separately identifiable values .
customer relationships represents suros large installed base that are expected to purchase disposable products on a regular basis .
trademarks represent the suros product names that the company intends to continue to use .
developed technology represents currently marketable purchased products that the company continues to resell as well as utilize to enhance and incorporate into the company 2019s existing products .
the estimated $ 4900 of purchase price allocated to in-process research and development projects primarily related to suros 2019 disposable products .
the projects are of various stages of completion and include next generation handpiece and site marker technologies .
the company expects that these projects will be completed during fiscal 2007 .
the deferred income tax liability relates to the tax effect of acquired identifiable intangible assets , and fair value adjustments to acquired inventory as such amounts are not deductible for tax purposes , partially offset by acquired net operating loss carry forwards that the company believes are realizable .
for all of the acquisitions discussed above , goodwill represents the excess of the purchase price over the net identifiable tangible and intangible assets acquired .
the company determined that the acquisition of each aeg , r2 and suros resulted in the recognition of goodwill primarily because of synergies unique to the company and the strength of its acquired workforce .
supplemental pro-forma information the following unaudited pro forma information presents the consolidated results of operations of the company , r2 and suros as if the acquisitions had occurred at the beginning of each of fiscal 2006 and 2005 .

Question: Analyse this data from a financial earnings document. what percentage of the estimated purchase price is due to developed technology and know how?
Choices:
228.85572
0.07215
11412600000
185.40911
0.18541
Correct choice index: 4